Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free EAH Stock Alerts

ECO Animal Health Group (EAH) Competitors

ECO Animal Health Group logo
GBX 100 0.00 (0.00%)
As of 07/31/2026 12:33 PM Eastern
Compare

EAH vs. BXP, ANCR, VLG, STX, and DNL

Should you buy ECO Animal Health Group stock or one of its competitors? MarketBeat compares ECO Animal Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ECO Animal Health Group include Beximco Pharmaceuticals (BXP), Animalcare Group (ANCR), Venture Life Group (VLG), Shield Therapeutics (STX), and Diurnal Group (DNL).

How does ECO Animal Health Group compare to Beximco Pharmaceuticals?

Beximco Pharmaceuticals (LON:BXP) and ECO Animal Health Group (LON:EAH) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

Beximco Pharmaceuticals has higher revenue and earnings than ECO Animal Health Group. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beximco Pharmaceuticals£53.93B0.00£970.84B£1.94 thousand0.03
ECO Animal Health Group£85.81M0.78£1.05M£4.3922.78

In the previous week, Beximco Pharmaceuticals had 1 more articles in the media than ECO Animal Health Group. MarketBeat recorded 1 mentions for Beximco Pharmaceuticals and 0 mentions for ECO Animal Health Group. Beximco Pharmaceuticals' average media sentiment score of 0.00 equaled ECO Animal Health Group'saverage media sentiment score.

Company Overall Sentiment
Beximco Pharmaceuticals Neutral
ECO Animal Health Group Neutral

Beximco Pharmaceuticals has a net margin of 16.76% compared to ECO Animal Health Group's net margin of 2.50%. Beximco Pharmaceuticals' return on equity of 11.99% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Beximco Pharmaceuticals16.76% 11.99% 6.97%
ECO Animal Health Group 2.50%2.55%2.14%

0.3% of Beximco Pharmaceuticals shares are owned by institutional investors. Comparatively, 40.8% of ECO Animal Health Group shares are owned by institutional investors. 4.2% of Beximco Pharmaceuticals shares are owned by insiders. Comparatively, 11.2% of ECO Animal Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Beximco Pharmaceuticals has a beta of 0.251, indicating that its stock price is 75% less volatile than the broader market. Comparatively, ECO Animal Health Group has a beta of 0.004, indicating that its stock price is 100% less volatile than the broader market.

ECO Animal Health Group has a consensus price target of GBX 160, suggesting a potential upside of 60.00%. Given ECO Animal Health Group's stronger consensus rating and higher probable upside, analysts plainly believe ECO Animal Health Group is more favorable than Beximco Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beximco Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Beximco Pharmaceuticals beats ECO Animal Health Group on 8 of the 15 factors compared between the two stocks.

How does ECO Animal Health Group compare to Animalcare Group?

ECO Animal Health Group (LON:EAH) and Animalcare Group (LON:ANCR) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment.

Animalcare Group has higher revenue and earnings than ECO Animal Health Group. ECO Animal Health Group is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECO Animal Health Group£85.81M0.78£1.05M£4.3922.78
Animalcare Group£89.11M2.60£36.55M£7.3045.89

ECO Animal Health Group currently has a consensus target price of GBX 160, indicating a potential upside of 60.00%. Given ECO Animal Health Group's stronger consensus rating and higher probable upside, research analysts clearly believe ECO Animal Health Group is more favorable than Animalcare Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Animalcare Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, ECO Animal Health Group's average media sentiment score of 0.00 equaled Animalcare Group'saverage media sentiment score.

Company Overall Sentiment
ECO Animal Health Group Neutral
Animalcare Group Neutral

ECO Animal Health Group has a beta of 0.004, meaning that its stock price is 100% less volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market.

Animalcare Group has a net margin of 5.70% compared to ECO Animal Health Group's net margin of 2.50%. Animalcare Group's return on equity of 4.46% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ECO Animal Health Group2.50% 2.55% 2.14%
Animalcare Group 5.70%4.46%2.97%

40.8% of ECO Animal Health Group shares are owned by institutional investors. Comparatively, 14.3% of Animalcare Group shares are owned by institutional investors. 11.2% of ECO Animal Health Group shares are owned by insiders. Comparatively, 30.1% of Animalcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Animalcare Group beats ECO Animal Health Group on 10 of the 14 factors compared between the two stocks.

How does ECO Animal Health Group compare to Venture Life Group?

ECO Animal Health Group (LON:EAH) and Venture Life Group (LON:VLG) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

ECO Animal Health Group has higher revenue and earnings than Venture Life Group. Venture Life Group is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECO Animal Health Group£85.81M0.78£1.05M£4.3922.78
Venture Life Group£35.17M2.40£747.21K£4.3715.93

ECO Animal Health Group has a beta of 0.004, indicating that its stock price is 100% less volatile than the broader market. Comparatively, Venture Life Group has a beta of 0.217, indicating that its stock price is 78% less volatile than the broader market.

In the previous week, Venture Life Group had 2 more articles in the media than ECO Animal Health Group. MarketBeat recorded 2 mentions for Venture Life Group and 0 mentions for ECO Animal Health Group. Venture Life Group's average media sentiment score of 0.49 beat ECO Animal Health Group's score of 0.00 indicating that Venture Life Group is being referred to more favorably in the news media.

Company Overall Sentiment
ECO Animal Health Group Neutral
Venture Life Group Neutral

ECO Animal Health Group currently has a consensus price target of GBX 160, indicating a potential upside of 60.00%. Given ECO Animal Health Group's stronger consensus rating and higher probable upside, research analysts clearly believe ECO Animal Health Group is more favorable than Venture Life Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Venture Life Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Venture Life Group has a net margin of 17.42% compared to ECO Animal Health Group's net margin of 2.50%. Venture Life Group's return on equity of 7.82% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ECO Animal Health Group2.50% 2.55% 2.14%
Venture Life Group 17.42%7.82%1.56%

40.8% of ECO Animal Health Group shares are owned by institutional investors. Comparatively, 21.9% of Venture Life Group shares are owned by institutional investors. 11.2% of ECO Animal Health Group shares are owned by company insiders. Comparatively, 7.5% of Venture Life Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

ECO Animal Health Group beats Venture Life Group on 10 of the 16 factors compared between the two stocks.

How does ECO Animal Health Group compare to Shield Therapeutics?

ECO Animal Health Group (LON:EAH) and Shield Therapeutics (LON:STX) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

In the previous week, Shield Therapeutics had 4 more articles in the media than ECO Animal Health Group. MarketBeat recorded 4 mentions for Shield Therapeutics and 0 mentions for ECO Animal Health Group. Shield Therapeutics' average media sentiment score of 0.66 beat ECO Animal Health Group's score of 0.00 indicating that Shield Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
ECO Animal Health Group Neutral
Shield Therapeutics Positive

ECO Animal Health Group has a beta of 0.004, suggesting that its stock price is 100% less volatile than the broader market. Comparatively, Shield Therapeutics has a beta of 1.76, suggesting that its stock price is 76% more volatile than the broader market.

ECO Animal Health Group has a net margin of 2.50% compared to Shield Therapeutics' net margin of -35.72%. Shield Therapeutics' return on equity of 121.87% beat ECO Animal Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ECO Animal Health Group2.50% 2.55% 2.14%
Shield Therapeutics -35.72%121.87%-47.85%

ECO Animal Health Group has higher revenue and earnings than Shield Therapeutics. Shield Therapeutics is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECO Animal Health Group£85.81M0.78£1.05M£4.3922.78
Shield Therapeutics£49.70M0.85-£36.28M-£2.00N/A

40.8% of ECO Animal Health Group shares are held by institutional investors. Comparatively, 6.7% of Shield Therapeutics shares are held by institutional investors. 11.2% of ECO Animal Health Group shares are held by insiders. Comparatively, 3.0% of Shield Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

ECO Animal Health Group presently has a consensus target price of GBX 160, suggesting a potential upside of 60.00%. Shield Therapeutics has a consensus target price of GBX 15, suggesting a potential upside of 279.75%. Given Shield Therapeutics' higher possible upside, analysts clearly believe Shield Therapeutics is more favorable than ECO Animal Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Shield Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

ECO Animal Health Group beats Shield Therapeutics on 8 of the 14 factors compared between the two stocks.

How does ECO Animal Health Group compare to Diurnal Group?

Diurnal Group (LON:DNL) and ECO Animal Health Group (LON:EAH) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

ECO Animal Health Group has higher revenue and earnings than Diurnal Group. Diurnal Group is trading at a lower price-to-earnings ratio than ECO Animal Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diurnal Group£4.68M0.00N/A-£8.50N/A
ECO Animal Health Group£85.81M0.78£1.05M£4.3922.78

In the previous week, Diurnal Group had 1 more articles in the media than ECO Animal Health Group. MarketBeat recorded 1 mentions for Diurnal Group and 0 mentions for ECO Animal Health Group. Diurnal Group's average media sentiment score of 0.59 beat ECO Animal Health Group's score of 0.00 indicating that Diurnal Group is being referred to more favorably in the media.

Company Overall Sentiment
Diurnal Group Positive
ECO Animal Health Group Neutral

ECO Animal Health Group has a net margin of 2.50% compared to Diurnal Group's net margin of 0.00%. ECO Animal Health Group's return on equity of 2.55% beat Diurnal Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Diurnal GroupN/A N/A N/A
ECO Animal Health Group 2.50%2.55%2.14%

40.8% of ECO Animal Health Group shares are owned by institutional investors. 11.2% of ECO Animal Health Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ECO Animal Health Group has a consensus price target of GBX 160, indicating a potential upside of 60.00%. Given ECO Animal Health Group's stronger consensus rating and higher possible upside, analysts clearly believe ECO Animal Health Group is more favorable than Diurnal Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Diurnal Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ECO Animal Health Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

ECO Animal Health Group beats Diurnal Group on 11 of the 13 factors compared between the two stocks.

Get ECO Animal Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for EAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EAH vs. The Competition

Export
MetricECO Animal Health GroupPharmaceuticals IndustryHealthcare SectorLON Exchange
Market Cap£67.09M£12.78B£7.16B£2.79B
Dividend Yield0.94%2.73%2.59%6.15%
P/E Ratio22.78799.05282.25368.29
Price / Sales0.78751.69591.8883,501.30
Price / Cash6.0514.8228.6027.89
Price / Book0.7310.3910.937.04
Net Income£1.05M£2.83B£3.50B£5.89B
7 Day Performance4.17%-0.18%-0.64%6.05%
1 Month Performance6.95%-4.04%-3.78%-0.22%
1 Year Performance31.58%156.15%61.99%63.72%

ECO Animal Health Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EAH
ECO Animal Health Group
N/AGBX 100
flat		GBX 160
+60.0%		+31.6%£67.09M£85.81M22.78234
BXP
Beximco Pharmaceuticals
N/AGBX 53
flat		N/A+35.9%£236.44M£53.93B0.035,500
ANCR
Animalcare Group
N/AGBX 334.80
flat		N/AN/A£231.17M£89.11M45.86220
VLG
Venture Life Group
N/AGBX 69.30
flat		N/A+13.6%£84.07M£35.17M15.86165
STX
Shield Therapeutics
1.5822 of 5 stars		GBX 6.01
flat		GBX 15
+149.6%		-12.2%£64.28M£49.70MN/A40,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:EAH) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel